Tenax Therapeutics
Price & Volume
Stats
See more52W Range | $4.63-$9.70 |
Market Cap | $59.1M |
Shares Short | 758,227 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.74 |
News
See moreYahoo Finance • 15 days ago
Tenax Therapeutics GAAP EPS of -$0.40 beats by $0.72
Yahoo Finance • 16 days ago
Tenax Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Yahoo Finance • 2 months ago
Tenax Therapeutics Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF
Yahoo Finance • 3 months ago
Tenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025
About
CEO | Mr. Christopher T. Giordano |
CFO | Mr. Thomas A. McGauley |
Address | 101 Glen Lennox Drive, Chapel Hill, NC, United States, 27517 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 4 |
